Collegium Pharmaceutical Inc (COLL) Hedge Fund & Institutional Holdings (Q2 2026)

COLL ranks #2264 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

281 institutions disclose a position in COLL, but none treat it as a major bet — even Ballast Asset Management, LP, its most concentrated holder, allocates just 1.6% of its own portfolio to it.

SummerHaven Investment Management, LLC has added to its COLL position for two straight quarters, increasing it by $171.2K to reach $923.7K today.

State of Alaska, Department of Revenue has trimmed its COLL position for two straight quarters, cutting it by $472.0K while still holding $255.0K.

COLL is up 0% today, and institutions have been net buyers of $138.7M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

COLL posted net income of $47.9M over the trailing twelve months, and currently trades at a P/E of 19.2.

• Profitable — net income of $47.9M over the trailing twelve months
• Revenue grew 14.3% year over year
• Net income improved year over year, from $36.3M to $47.9M
• Generated $329.3M in positive operating cash flow
• Current ratio of 1.57x — enough short-term assets to cover short-term liabilities
• Liabilities run 4.49x equity — a highly leveraged balance sheet worth noting